학술논문

HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
Document Type
article
Source
AIDS. 34(5)
Subject
Biomedical and Clinical Sciences
Public Health
Health Sciences
Clinical Sciences
Prevention
Clinical Trials and Supportive Activities
HIV/AIDS
Kidney Disease
Clinical Research
Sexually Transmitted Infections
Infectious Diseases
Renal and urogenital
Adult
Aged
Anti-HIV Agents
Biomarkers
Creatinine
Cystatin C
Emtricitabine
Female
HIV Infections
Humans
Kidney
Kidney Function Tests
Kidney Glomerulus
Longitudinal Studies
Male
Middle Aged
Pre-Exposure Prophylaxis
Tenofovir
alpha-1 microglobulin
cystatin C
HIV prevention
nephrotoxicity
preexposure prophylaxis
tenofovir
urine biomarkers
Biological Sciences
Medical and Health Sciences
Psychology and Cognitive Sciences
Virology
Biomedical and clinical sciences
Health sciences
Language
Abstract
ObjectiveTo evaluate the effects of HIV preexposure prophylaxis (PrEP) with tenofovir disoproxial fumurate (TDF)/emtricitabine (FTC) on kidney function and kidney tubular health.DesignThe Iniciativa Profilaxis Pre-Exposicion open-label extension (iPrEx-OLE) study enrolled former PrEP trial participants to receive open-label TDF/FTC. This study included 123 iPrEx-OLE participants who demonstrated PrEP adherence.MethodsWe compared estimated glomerular filtration rate calculated using serum creatinine (eGFRcr), serum cystatin C (eGFRcys), and in combination (eGFRcr-cys), and a panel of 14 urine biomarkers reflecting kidney tubular health before and 6 months after PrEP initiation.ResultsAt baseline, mean eGFRcr, eGFRcys, and eGFRcr-cys were 108.3, 107.0, and 111.1 ml/min per 1.73 m, respectively. Six months after PrEP initiation, eGFRcr declined by -4% (95% CI: -5.7 to -2.4%), eGFRcys declined by -3.3% (95% CI: -8.3 to 1.9%), and eGFRcr-cys declined by -4.1% (95% CI: -7.5 to -0.7%). From the urine biomarker panel, α1-microglobulin and β2-microglobulin increased by 22.7% (95% CI: 11.8--34.7%) and 14.1% (95% CI: -6.1 to 38.6%), whereas chitinase-3-like 1 protein and monocyte chemoattractant protein-1 decreased by -37.7% (95% CI: -53.0 to -17.3%) and -15.6% (95% CI: -31.6 to 4.2%), respectively. Ten of the 14 urine biomarkers, including albumin, had estimated changes of less than 12% with wide confidence intervals.ConclusionSix months of PrEP with TDF/FTC was associated with decreases in eGFRcr and eGFRcys. We also observed for the first time changes in flour of 14 urine biomarkers reflecting kidney tubular health. These findings demonstrate that PrEP has direct effects on eGFR and the proximal tubule.